US Hemp Industry In Limbo As FDA Deadline For Cannabinoid Definitions Arrives
There is a bipartisan legislation in the works to delay the ban until 2028
The Food and Drug Administration’s (FDA) 90-day deadline to clarify which cannabinoids will be banned under the incoming, controversial intoxicating hemp ban falls today.
With little in the way of detail offered by the Federal Government since the ban was passed in November 2025, the US intoxicating hemp industry, thought to be worth tens-of-billions of dollars, is currently in the dark about the future legality of its operations.
As the sweeping ban set to come into force in November 2026, the FDA was tasked with publishing lists clarifying what will be classed as naturally occurring cannabinoids, THC-class compounds, and substances with THC-like effects.
Yet even as the deadline passes without clarity, Congress has begun advancing competing alternatives: bipartisan legislation to delay the ban until 2028, and a separate regulatory framework that would replace prohibition with age-restricted controls and potency limits.
To Read The Rest Of This Article On Business of Cannabis, Click Here
